Are you saying that a company like Colossal has nothing to offer to the field of genetic biocontrol or are you saying there is nothing of interest in the field?
I'm saying that even if they can do it, which nothing so far suggests, then the enormous prior art in the field should still make it uninteresting to them in any case. Nothing you could patent, and it isn't charismatic to billionaires. Why bother?
